Tag: stent retriever

Gravity Medical Technology has announced the launch of its next-generation stroke treatment devices: the Neutron aspiration catheter and the Supernova stent retriever. Early adoption...

A retrospective analysis including data from close to 3,000 stroke patients has concluded that early changes in mechanical thrombectomy strategies may be associated with...

NOTE: This video is ONLY available to watch in selected countries and geographies Edgar Samaniego (University of Iowa, Iowa City, USA) discusses his experiences...

A subgroup analysis of the ASTER2 clinical trial has found that a first-line combined thrombectomy approach, which involves using contact aspiration and a stent...

Late-breaking findings from the TWIN2WIN trial—presented recently at the International Stroke Conference (ISC; 7–9 February, Phoenix, USA)—have demonstrated the potential benefits of performing mechanical...

Final results from the PROST randomised controlled trial (RCT) have been published in JAMA Neurology and—according to the study’s leading investigators—provide evidence that thrombectomy...

Rapid Medical has announced Japanese approval for its Tigertriever revascularisation device. With Pharmaceuticals and Medical Devices Agency (PMDA) approval, Tigertriever serves as “the first...

Research presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has shown that different types of...

When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...

New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...

This advertorial is sponsored by CERENOVUS. The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design...

Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...

NeuroVasc Technologies recently announced that the first patient has been treated in its US investigational device exemption (IDE) clinical study, the ENVI randomised controlled...

A relatively new introduction to the field of endovascular therapy (EVT) for acute ischaemic stroke, the Skyflow stent retriever (Skyflow), has demonstrated non-inferiority with...

This advertorial is sponsored by Perflow. The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...

Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...

US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...

Rapid Medical has announced CE mark approval for Tigertriever XL stentriever. The company noted that the first patients have been treated successfully with the...

Advertorial While the treatment paradigm for stroke continues to evolve, even a quick review of the current literature will point to how complete reperfusion...

The first randomised controlled trial (RCT) to directly compare the efficacy of the combined use of contact aspiration and stent retriever against a stent...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...

Longer stent retrievers were found independently associated with higher rates of first-pass reperfusion and should be favoured over their shorter counterparts in light of...

In this educational supplement we focus on ischaemic stroke. We look at the results of the ASTER trial and experts weigh in on the...

The final results of the ASTER randomised controlled trial have confirmed that there was no statistically significant difference between ADAPT (a direct aspiration first...

A new study comparing acute damage to the arterial wall caused by ADAPT (a direct aspiration first pass technique) or stent retrievers during thrombectomy...

Now that mechanical thrombectomy for the treatment of acute ischaemic stroke is on its way to becoming well-established practice, new devices are beginning to...

Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will...

The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic...

The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...

Stent retriever technology has been named by the Cleveland Clinic as a top medical innovation. It was part of a list of the top...

With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.